Manning & Napier Group's AMGN Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 65 shares of Amgen Inc. (AMGN) worth $18,343, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2016, adding 64.5K shares. Largest reduction occurred in Q1 2020, reducing 178.6K shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Amgen (AMGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amgen (AMGN) Trades by Manning & Napier Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +128,898 | Add 0.00% | 128,897 | $98.65 |
| Q3 2013 | -123,656 | Reduce 95.93% | 5,241 | $111.81 |
| Q4 2013 | -5,241 | Sold Out | 5,241 | $0.00 |
| Q2 2016 | +69,758 | New Buy | 69,758 | $152.13 |
| Q3 2016 | -1,263 | Reduce 1.81% | 68,495 | $166.79 |
| Q4 2016 | +2,508 | Add 3.66% | 71,003 | $146.19 |
| Q1 2017 | +3,378 | Add 4.76% | 74,381 | $164.05 |
| Q2 2017 | +40,789 | Add 54.84% | 115,170 | $172.22 |
| Q3 2017 | -425 | Reduce 0.37% | 114,745 | $186.43 |
| Q4 2017 | +106,786 | Add 0.00% | 106,785 | $173.88 |
| Q1 2018 | +18,371 | Add 17.20% | 125,156 | $170.47 |
| Q2 2018 | -7,593 | Reduce 6.07% | 117,563 | $184.58 |
| Q3 2018 | +7,370 | Add 6.27% | 124,933 | $207.28 |
| Q4 2018 | +9,461 | Add 7.57% | 134,394 | $194.66 |
| Q1 2019 | +35,379 | Add 26.32% | 169,773 | $189.97 |
| Q2 2019 | +12,735 | Add 7.50% | 182,508 | $184.28 |
| Q3 2019 | +161 | Add 0.09% | 182,669 | $193.50 |
| Q4 2019 | +18,838 | Add 10.31% | 201,507 | $241.06 |
| Q1 2020 | -178,613 | Reduce 88.64% | 22,894 | $202.72 |
| Q2 2020 | -21,894 | Reduce 95.63% | 1,000 | $235.00 |
| Q3 2021 | -1,000 | Sold Out | 1,000 | $0.00 |
| Q3 2025 | +65 | New Buy | 65 | $282.20 |
Manning & Napier Group's Amgen Investment FAQs
Manning & Napier Group first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 128,897 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Amgen Inc. (AMGN) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's largest addition to Amgen Inc. (AMGN) was in Q2 2013, adding 128,897 shares worth $12.72 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 65 shares of Amgen Inc. (AMGN), valued at approximately $18,343. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Amgen Inc. (AMGN) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group's peak holding in Amgen Inc. (AMGN) was 201,507 shares, as reported at the end of Q4 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.